🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Joel Greenblatt’s MNMD Holdings & Trades

First Buy
Q2 2025
Duration Held
3 Quarters
Largest Add
Q2 2025
+14,078 Shares
Current Position
17,825 Shares
$238,677 Value

Joel Greenblatt's MNMD Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 17,825 shares of Mind Medicine (MindMed) Inc. (MNMD) worth $238,677, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.

Based on 13F filings, Joel Greenblatt has maintained this position in MNMD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 2,924 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Mind Medicine (MindMed) (MNMD) Holding Value Over Time

Track share changes against reported price movement

Quarterly Mind Medicine (MindMed) (MNMD) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +823 Add 4.84% 17,825 $13.39
Q3 2025 +2,924 Add 20.77% 17,002 $11.79
Q2 2025 +14,078 New Buy 14,078 $6.49

Joel Greenblatt's Mind Medicine (MindMed) Investment FAQs

Joel Greenblatt first purchased Mind Medicine (MindMed) Inc. (MNMD) in Q2 2025, acquiring 14,078 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Mind Medicine (MindMed) Inc. (MNMD) for 3 quarters since Q2 2025.

Joel Greenblatt's largest addition to Mind Medicine (MindMed) Inc. (MNMD) was in Q2 2025, adding 14,078 shares worth $91,366.

According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 17,825 shares of Mind Medicine (MindMed) Inc. (MNMD), valued at approximately $238,677.

As of the Q4 2025 filing, Mind Medicine (MindMed) Inc. (MNMD) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in Mind Medicine (MindMed) Inc. (MNMD) was 17,825 shares, as reported at the end of Q4 2025.